Results 61 to 70 of about 56,993 (185)

Evaluation of presentation, treatment and outcome in dogs with granulomatous steatitis associated with hypercalcaemia: six cases (2019‐2023)

open access: yesJournal of Small Animal Practice, Volume 65, Issue 9, Page 704-712, September 2024.
Objectives To report the presentation, treatment and outcome of dogs with granulomatous steatitis associated with total and ionised hypercalcaemia. Methods Six dogs diagnosed with ionised and/or total hypercalcaemia and histologically diagnosed granulomatous steatitis were evaluated to determine the clinical signs, clinical findings, response to ...
H. Reyes‐Hughes   +6 more
wiley   +1 more source

Demystifying normal‐anion‐gap metabolic acidosis: pathophysiology, aetiology, evaluation and diagnosis

open access: yesInternal Medicine Journal, Volume 54, Issue 7, Page 1056-1065, July 2024.
Abstract Normal‐anion‐gap metabolic acidosis (NAGMA) is a common but often under‐recognised and poorly understood condition, especially by less‐experienced clinicians. In adults, NAGMA might be an initial clue to a more significant underlying pathology, such as autoimmune diseases, hypergammaglobulinemia or drug toxicities.
Ritesh Bhandari   +2 more
wiley   +1 more source

COLON PERFORATION IN TWO HEMODIALYSIS PATIENTS ON SEVELAMER HYDROCHLORIDE

open access: yesNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 2008
塩酸セベラマーを内服中の透析患者に発生した結腸穿孔を2例経験したため報告する.症例1は70歳代,女性.透析歴8年.2004年3月に腹痛,嘔吐のため当院に救急搬送された.CTで腸管穿孔と診断し,緊急開腹術を行った.下行結腸に穿孔と硬便の突出を認め,結腸部分切除,人工肛門造設術を施行した.術後に敗血症,DIC,小腸皮膚瘻を合併したが,集学的治療で改善し,軽快退院した.症例2は50歳代,女性.透析歴10年.2006年12月,入院中に腹痛,嘔吐が出現し,CTでS状結腸穿孔と診断し緊急開腹術を行った.大腸全体に硬便が貯留し,S状結腸に穿孔と便塊の突出を認め,S状結腸部分切除,人工肛門造設術を施行した.翌日より維持透析を再開し,経過良好で軽快退院した ...
NISHIWADA, Satoshi   +4 more
openaire   +2 more sources

Determinants of hyperparathyroidism in children after kidney transplantation

open access: yesClinical Transplantation, Volume 38, Issue 3, March 2024.
Abstract Introduction Hyperparathyroidism (HPT) can contribute to metabolic bone disease following kidney transplantation. We evaluated post‐transplant trends in intact parathyroid hormone (iPTH) and determined predictors of HPT in pediatric kidney transplant (KTx) recipients. Methods In this single‐center study, retrospective data were collected on 88
Wendy Glaberson   +9 more
wiley   +1 more source

Chronic acid-base perturbations in hemodialysis patients treated with sevelamer hydrochloride: A two-year follow-up study

open access: yes, 2007
Sevelamer hydrochloride (HCl) contains multiple amines that may cause a significant dietary acid load. To evaluate the impact of sevelamer on arterial blood gases, we followed two groups of stable hemodialysis patients for 24 months. The Sevelamer Group (
Vlahakos, Demetrios V.   +5 more
core   +1 more source

PATIENTS RECEIVING HEMODIALYSIS WITH THE NURSING DIAGNOSIS OF FLUID VOLUME EXCESS: SOCIOECONOMIC AND CLINICAL ASPECTS

open access: yesCogitare Enfermagem, 2015
This study aimed to describe socioeconomic and clinical aspects of chronic kidney patients receiving hemodialysis, with the nursing diagnosis of Fluid Volume Excess. It is a transversal study, undertaken in a teaching hospital and hemodialysis clinic in
Maria Isabel da Conceição Dias Fernandes Cavalcanti   +5 more
doaj   +1 more source

Sevelamer hydrochloride for tumor lysis syndrome-related hyperphosphatemia

open access: yesIndian Pediatrics, 2015
Tumour lysis syndrome is associated with high levels of uric acid, phosphate and potassium along with low levels of calcium and abnormal renal function. Sevelamer, an oral phosphate-binder is used in the treatment of hyperphosphatemia in children and adults on hemodialysis.Two children with T-cell acute lymphoblastic leukemia who presented with a high ...
openaire   +2 more sources

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients [PDF]

open access: yes, 2009
Sevelamer hydrochloride (HCl), a calcium-free phosphate binder, is increasingly used due to concerns related to calcium exposure and the development of vascular calcifications.
Amin, Nimisha   +9 more
core   +1 more source

RELATIVE DOSING OF PHOSPHATE BINDERS FOR EFFECTIVE MANAGEMENT OF PHOSPHATE AND PROTEIN INTAKE IN CHRONIC KIDNEY DISEASE

open access: yesKidney Research and Clinical Practice, 2012
Patients with chronic kidney disease undergoing haemodialysis have a maximum recommended dietary phosphate (P) intake of 1000 mg/day and a recommended protein intake of 1.2 g/kg/day.
J Brian Copley, Jamie Heise
doaj   +1 more source

Efficacy of single administration of sevelamer hydrochloride in hemodialysis patients

open access: yesNihon Toseki Igakkai Zasshi, 2005
維持血液透析患者における, sevelamer hydrochloride (以下sevelamer) の効果について検討した. 週3回, 4時間以上の維持血液透析を1年以上施行しており, Pi 5.5mg/dL以上, 補正Ca 9.5mg/dL以上の, 炭酸カルシウムを内服している患者20例 (男性15例, 女性5例) を対象とした. 炭酸カルシウムおよびその他のリン吸着剤はすべて中止し, sevelamerを8週間投与した. sevelamerの初期投与量および増減は, 原則として添付文書に従い, 消化器症状等の副作用も考慮して決定した.
Ohno, Akira   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy